6533b838fe1ef96bd12a50aa
RESEARCH PRODUCT
Teprotumumab for the treatment of active thyroid eye disease
Saba SileThomas VescioRobert J. HoltGeorge J. KahalyAlessandro AntonelliRoger A. DaileyGerald J. HarrisClaudio MarcocciAmy PatelRosa A. TangJames C. FlemingElizabeth H.z. ThompsonMario SalviSara T. WesterAnja EcksteinBrian T. FowlerTerry J. SmithJeffrey W. ShermanChristine C. NelsonJade S. SchiffmanMichele MarinòRaymond S DouglasRenee Perdoksubject
Drugmedicine.medical_specialtyBlindingmedia_common.quotation_subjectEye diseaseMedizin030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawOphthalmologymedicine030212 general & internal medicinemedia_commonTeprotumumabbusiness.industryThyroidGeneral Medicinemedicine.diseaseDermatologyeye diseasesClinical trialmedicine.anatomical_structuresense organsbusinessMedical therapymedicine.drugdescription
Abstract Background Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition for which no Food and Drug Administration–approved medical therapy is available...
year | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 |